151 related articles for article (PubMed ID: 16521405)
21. Association of p53 Arg72Pro polymorphism and beta-catenin accumulation in mycosis fungoides.
Bellei B; Cota C; Amantea A; Muscardin L; Picardo M
Br J Dermatol; 2006 Dec; 155(6):1223-9. PubMed ID: 17107393
[TBL] [Abstract][Full Text] [Related]
22. Endothelin-1 gene variant Lys198Asn and plasma endothelin level in obstructive sleep apnea.
Diefenbach K; Kretschmer K; Bauer S; Malzahn U; Penzel T; Roots I; Fietze I
Cardiology; 2009; 112(1):62-8. PubMed ID: 18580062
[TBL] [Abstract][Full Text] [Related]
23. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.
Geskin L
Skin Therapy Lett; 2007 Jun; 12(5):1-4. PubMed ID: 17609808
[TBL] [Abstract][Full Text] [Related]
24. Infantile-onset cutaneous T-cell lymphoma.
Tsianakas A; Kienast AK; Hoeger PH
Br J Dermatol; 2008 Dec; 159(6):1338-41. PubMed ID: 18717674
[TBL] [Abstract][Full Text] [Related]
25. Clinical experience: practical management of five patients with cutaneous T-cell lymphoma (CTCL)-related symptoms.
Dummer R; Foss F; Dreno B; Bagot M
Semin Oncol; 2006 Feb; 33(1 Suppl 3):S26-32. PubMed ID: 16516673
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous T-cell lymphoma and Staphylococcus aureus colonization.
Nguyen V; Huggins RH; Lertsburapa T; Bauer K; Rademaker A; Gerami P; Guitart J
J Am Acad Dermatol; 2008 Dec; 59(6):949-52. PubMed ID: 18835065
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and significance of human parvovirus variants in skin from primary cutaneous T cell lymphomas, inflammatory dermatoses and healthy subjects.
Sidoti F; Fierro MT; Costa C; Ponti R; Bergallo M; Comessatti A; Fumagalli M; Novelli M; Merlino C; Cavallo R; Bernengo MG
Arch Dermatol Res; 2009 Oct; 301(9):647-52. PubMed ID: 19387672
[TBL] [Abstract][Full Text] [Related]
28. Phototherapy of cutaneous T-cell lymphomas.
Trautinger F
Photochem Photobiol Sci; 2018 Dec; 17(12):1904-1912. PubMed ID: 30325389
[TBL] [Abstract][Full Text] [Related]
29. T-cell technology in the diagnosis & management of cutaneous T-cell lymphoma.
Duncan KO; Heald PW
Compr Ther; 1998 Mar; 24(3):117-22. PubMed ID: 9559245
[TBL] [Abstract][Full Text] [Related]
30. Controversies in the management of the cutaneous T cell lymphomas.
Zic JA
Dermatol Ther; 2009; 22(5):407-17. PubMed ID: 19845718
[TBL] [Abstract][Full Text] [Related]
31. The optimal use of bexarotene in cutaneous T-cell lymphoma.
Gniadecki R; Assaf C; Bagot M; Dummer R; Duvic M; Knobler R; Ranki A; Schwandt P; Whittaker S
Br J Dermatol; 2007 Sep; 157(3):433-40. PubMed ID: 17553039
[TBL] [Abstract][Full Text] [Related]
32. Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma.
Ellis L; Pan Y; Smyth GK; George DJ; McCormack C; Williams-Truax R; Mita M; Beck J; Burris H; Ryan G; Atadja P; Butterfoss D; Dugan M; Culver K; Johnstone RW; Prince HM
Clin Cancer Res; 2008 Jul; 14(14):4500-10. PubMed ID: 18628465
[TBL] [Abstract][Full Text] [Related]
33. Phototherapy for cutaneous T-cell lymphoma: online survey and literature review.
Carter J; Zug KA
J Am Acad Dermatol; 2009 Jan; 60(1):39-50. PubMed ID: 18842323
[TBL] [Abstract][Full Text] [Related]
34. Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma.
Bisaccia E; Vonderheid EC; Geskin L
Br J Dermatol; 2009 Jul; 161(1):167-9. PubMed ID: 19298276
[TBL] [Abstract][Full Text] [Related]
35. Extracorporeal photochemotherapy in patients with cutaneous T-cell lymphoma: is clinical response predictable?
Rao V; Ryggen K; Aarhaug M; Dai HY; Jørstad S; Moen T
J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1100-7. PubMed ID: 16987266
[TBL] [Abstract][Full Text] [Related]
36. [Current approaches to diagnosing and treating primary cutaneous lymphomas on the basis of a new WHO-EORTC classification, cutaneous T-cell lymphomas].
Belousova IE; Kazakov DV; Krivolapov IuA
Arkh Patol; 2007; 69(5):11-7. PubMed ID: 18074813
[TBL] [Abstract][Full Text] [Related]
37. The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat.
Massone C; Lozzi GP; Egberts F; Fink-Puches R; Cota C; Kerl H; Cerroni L
J Cutan Pathol; 2006 Jun; 33(6):418-25. PubMed ID: 16776717
[TBL] [Abstract][Full Text] [Related]
38. Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients.
Figl A; Scherer D; Nagore E; Bermejo JL; Dickes E; Thirumaran RK; Gast A; Hemminki K; Kumar R; Schadendorf D
Mutat Res; 2009 Feb; 661(1-2):78-84. PubMed ID: 19073198
[TBL] [Abstract][Full Text] [Related]
39. Significant impact of cutaneous T-cell lymphoma on patients' quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey.
Demierre MF; Gan S; Jones J; Miller DR
Cancer; 2006 Nov; 107(10):2504-11. PubMed ID: 17048251
[TBL] [Abstract][Full Text] [Related]
40. Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell Lymphoma.
Vašků V; Máchal J; Zlámal F; Vašků A
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
